News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

TG Therapeutics, Inc. (MHA) to Host Conference Call on Third Quarter 2012 Financial Results


11/7/2012 9:16:46 AM

NEW YORK, Nov. 7, 2012 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (OTCBB:TGTX), an innovative, clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of innovative and medically important pharmaceutical products for the treatment of cancer and other underserved therapeutic needs, today announced that a conference call will be held on Friday, November 9, 2012 at 8:30 a.m. EST to discuss results for the third quarter ended September 30, 2012 and a business outlook for the remainder of 2012. Michael S. Weiss, Executive Chairman and Interim Chief Executive Officer, will host the call.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES